<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2020-1S-15-19</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-1396</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ И МЕТОДИКИ</subject></subj-group></article-categories><title-group><article-title>The combined effect of nuclear and mitochondrial genomes on the risk of developing multiple sclerosis</article-title><trans-title-group xml:lang="ru"><trans-title>Сочетанное влияние ядерного и митохондриального геномов на риск развития рассеянного склероза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козин</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozin</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра неврологии, нейрохирургии и медицинской генетики; отдел нейроиммунологии</p><p>117997, Москва, ул. Островитянова, 1; 117997, Москва, ул. Островитянова, 1, стр. 10;121552, Москва, 3-я Черепковская ул., 15А</p></bio><bio xml:lang="en"><p>Department of Neurology, Neurosurgery, and Medical Genetics;Department of Neuroimmunology</p><p>1, Ostrovityanov St, Moscow 117997, Russia; 1, Ostrovityanov St, Build. 10, Moscow 117997, Russia; 15A, Third Cherepkovskaya St., Moscow 121552, Russia</p></bio><email xlink:type="simple">kozinmax1992@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Киселев</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kiselev</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра неврологии, нейрохирургии и медицинской генетики</p><p>117997, Москва, ул. Островитянова, 1; 121552, Москва, 3-я Черепковская ул., 15А</p></bio><bio xml:lang="en"><p>Department of Neurology, Neurosurgery, and Medical Genetics</p><p>1, Ostrovityanov St, Moscow 117997, Russia; 15A, Third Cherepkovskaya St., Moscow 121552, Russia</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бойко</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Boyko</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра неврологии, нейрохирургии и медицинской генетики; отдел нейроиммунологии</p><p>117997, Москва, ул. Островитянова, 1; 117997, Москва, ул. Островитянова, 1, стр. 10;</p></bio><bio xml:lang="en"><p>Department of Neurology, Neurosurgery, and Medical Genetics; Department of Neuroimmunology</p><p>1, Ostrovityanov St, Moscow 117997, Russia; 1, Ostrovityanov St, Build. 10, Moscow 117997, Russia</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулакова</surname><given-names>О. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulakova</surname><given-names>O. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра неврологии, нейрохирургии и медицинской генетики</p><p>117997, Москва, ул. Островитянова, 1; 121552, Москва, 3-я Черепковская ул., 15А</p></bio><bio xml:lang="en"><p>Department of Neurology, Neurosurgery, and Medical Genetics</p><p>1, Ostrovityanov St, Moscow 117997, Russia; 15A, Third Cherepkovskaya St., Moscow 121552, Russia</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фаворова</surname><given-names>О. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Favorova</surname><given-names>O. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра неврологии, нейрохирургии и медицинской генетики</p><p>117997, Москва, ул. Островитянова, 1; 121552, Москва, 3-я Черепковская ул., 15А</p></bio><bio xml:lang="en"><p>Department of Neurology, Neurosurgery, and Medical Genetics</p><p>1, Ostrovityanov St, Moscow 117997, Russia; 15A, Third Cherepkovskaya St., Moscow 121552, Russia</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России; &#13;
ФГБУ «Федеральный центр мозга и нейротехнологий» ФМБА; &#13;
Национальный медицинский исследовательский центр кардиологии Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; &#13;
Federal Center for the Brain and Neurotechnologies, Federal Biomedical Agency of Russia; &#13;
National Medical Research Center for Cardiology, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России; &#13;
Национальный медицинский исследовательский центр кардиологии Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; &#13;
National Medical Research Center for Cardiology, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России; &#13;
ФГБУ «Федеральный центр мозга и нейротехнологий» ФМБА;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; &#13;
Federal Center for the Brain and Neurotechnologies, Federal Biomedical Agency of Russia;</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>05</day><month>08</month><year>2020</year></pub-date><volume>12</volume><issue>1S</issue><issue-title>Спецвыпуск: рассеянный склероз</issue-title><fpage>15</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kozin M.S., Kiselev I.S., Boyko A.N., Kulakova O.G., Favorova O.O., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Козин М.С., Киселев И.С., Бойко А.Н., Кулакова О.Г., Фаворова О.О.</copyright-holder><copyright-holder xml:lang="en">Kozin M.S., Kiselev I.S., Boyko A.N., Kulakova O.G., Favorova O.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/1396">https://nnp.ima-press.net/nnp/article/view/1396</self-uri><abstract><p>Multiple sclerosis (MS) is a severe chronic CNS disease characterized by autoimmune inflammation, demyelination, and neurodegeneration. The interaction of mitochondrial and nuclear genomes is shown to be important in the formation of a predisposition to many diseases.</p><sec><title>Objective</title><p>Objective: to analyze the association of MS with the carriage of biallelic combinations, including as components the polymorphisms of three genes of mitochondrial DNA (mtDNA) and those of 16 nuclear genes, the products of which are involved in the functioning of the immune system and may participate in the development of autoimmune inflammation in MS; and, if these combinations are identified, to determine the nature of an interaction between their components. </p></sec><sec><title>Patients and methods</title><p>Patients and methods. The investigation enrolled 540 MS patients and 406 control group individuals; all were Russians. The mitochondrial genome was genotyped by polymerase chain reaction-restriction fragment length polymorphism analysis. APSampler software was used for multilocus association analysis. </p></sec><sec><title>Results and discussion</title><p>Results and discussion. The investigators identified five biallelic combinations that were associated with MS (p=0.0036–0.022) and possessed protective properties (odds ratio (OR) 0.67–0.75). The mitochondrial component of the identified combinations was the polymorphisms m.4580 (rs28357975), m.13368 (rs3899498), and m.13708 (rs28359178) mtDNA; the nuclear component was CXCR5 (rs523604), TNFRSF1A (rs1800693), and CD86 (rs2255214) gene polymorphisms. The interaction between the components of the identified combinations was additive. </p></sec><sec><title>Conclusion</title><p>Conclusion. The data obtained in the Russian population suggest that the combined contribution of the mitochondrial and nuclear genomes may affect the risk of developing MS.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Рассеянный склероз (РС) – тяжелое хроническое заболевание ЦНС, характеризующееся аутоиммунным воспалением, демиелинизацией и нейродегенерацией. В формировании предрасположенности ко многим заболеваниям показана важность взаимодействия митохондриального и ядерного геномов.</p><p>Цель работы – анализ ассоциации РС с носительством биаллельных сочетаний, включающих в качестве компонентов полиморфизмы трех генов митохондриальной ДНК (мтДНК) и полиморфизмы 16 ядерных генов, продукты которых вовлечены в функционирование иммунной системы и могут участвовать в развитии аутоиммунного воспаления при РС; в случае выявления таких сочетаний – определение характера взаимодействия между их компонентами.</p><sec><title>Пациенты и методы</title><p>Пациенты и методы. В исследование включено 540 пациентов с РС и 406 лиц контрольной группы, все русские. Генотипирование митохондриального генома проводили методом полимеразной цепной реакции с последующим анализом полиморфизма длин рестрикционных фрагментов. Для мультилокусного анализа ассоциации использовали программное обеспечение APSampler.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Выявлено пять биаллельных сочетаний, ассоциированных с РС (p=0,0036–0,022) и обладающих протективными свойствами (отношения шансов, ОШ 0,67–0,75). Митохондриальным компонентом выявленных сочетаний были полиморфизмы m.4580 (rs28357975), m.13368 (rs3899498) и m.13708 (rs28359178) мтДНК; ядерным компонентом – полиморфизмы генов CXCR5 (rs523604), TNFRSF1A (rs1800693) и CD86 (rs2255214). Взаимодействие между компонентами выявленных сочетаний носит аддитивный характер.</p></sec><sec><title>Заключение</title><p>Заключение. Полученные в русской популяции данные свидетельствуют о влиянии сочетанного вклада митохондриального и ядерного геномов на риск развития РС.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>рассеянный склероз</kwd><kwd>генетический полиморфизм</kwd><kwd>митохондриальный геном</kwd><kwd>ядерный геном</kwd><kwd>анализ ассоциации</kwd><kwd>мультилокусный анализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>multiple sclerosis</kwd><kwd>genetic polymorphism</kwd><kwd>mitochondrial genome</kwd><kwd>nuclear genome</kwd><kwd>association analysis</kwd><kwd>multilocus analysis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа подготовлена в рамках Государственного задания АААА-А19-119042590026-5.</funding-statement><funding-statement xml:lang="en">The work has been prepared under State Assignment AAAA-A19-119042590026-5</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Karussis D. The Diagnosis of Multiple Sclerosis and the Various Related Demyelinating Syndromes: A Critical Review. J Autoimmun. Feb-Mar 2014;48-49:134-42. doi: 10.1016/j.jaut.2014.01.022. Epub 2014 Feb 10.</mixed-citation><mixed-citation xml:lang="en">Karussis D. The Diagnosis of Multiple Sclerosis and the Various Related Demyelinating Syndromes: A Critical Review. J Autoimmun. Feb-Mar 2014;48-49:134-42. doi: 10.1016/j.jaut.2014.01.022. Epub 2014 Feb 10.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">International Multiple Sclerosis Genetics Consortium. Multiple Sclerosis Genomic Map Implicates Peripheral Immune Cells and Microglia in Susceptibility. Science. 2019 Sep 27;365 (6460):eaav7188. doi: 10.1126/science.aav7188.</mixed-citation><mixed-citation xml:lang="en">International Multiple Sclerosis Genetics Consortium. Multiple Sclerosis Genomic Map Implicates Peripheral Immune Cells and Microglia in Susceptibility. Science. 2019 Sep 27;365 (6460):eaav7188. doi: 10.1126/science.aav7188.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Maher B. Personal Genomes: The Case of the Missing Heritability. Nature. 2008 Nov 6;456(7218):18-21. doi: 10.1038/456018a.</mixed-citation><mixed-citation xml:lang="en">Maher B. Personal Genomes: The Case of the Missing Heritability. Nature. 2008 Nov 6;456(7218):18-21. doi: 10.1038/456018a.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell G, Mahad DJ. Mitochondrial Dysfunction and Axon Degeneration in Progressive Multiple Sclerosis. FEBS Lett. 2018 Apr;592(7):1113-1121. doi: 10.1002/1873-3468.13013. Epub 2018 Mar 25.</mixed-citation><mixed-citation xml:lang="en">Campbell G, Mahad DJ. Mitochondrial Dysfunction and Axon Degeneration in Progressive Multiple Sclerosis. FEBS Lett. 2018 Apr;592(7):1113-1121. doi: 10.1002/1873-3468.13013. Epub 2018 Mar 25.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kozin MS, Kulakova OG, Favorova OO. Involvement of Mitochondria in Neurodegeneration in Multiple Sclerosis. Biochemistry (Mosc). 2018 Jul;83(7):813-830. doi: 10.1134/S0006297918070052.</mixed-citation><mixed-citation xml:lang="en">Kozin MS, Kulakova OG, Favorova OO. Involvement of Mitochondria in Neurodegeneration in Multiple Sclerosis. Biochemistry (Mosc). 2018 Jul;83(7):813-830. doi: 10.1134/S0006297918070052.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lvovs D, Favorova OO, Favorov AV. A Polygenic Approach to the Study of Polygenic Diseases. Acta Naturae. 2012 Jul;4(3):59-71.</mixed-citation><mixed-citation xml:lang="en">Lvovs D, Favorova OO, Favorov AV. A Polygenic Approach to the Study of Polygenic Diseases. Acta Naturae. 2012 Jul;4(3):59-71.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dobler R, Dowling DK, Morrow EH, et al. A Systematic Review and Meta-Analysis Reveals Pervasive Effects of Germline Mitochondrial Replacement on Components of Health. Hum Reprod Update. 2018 Sep 1; 24(5):519-34.</mixed-citation><mixed-citation xml:lang="en">Dobler R, Dowling DK, Morrow EH, et al. A Systematic Review and Meta-Analysis Reveals Pervasive Effects of Germline Mitochondrial Replacement on Components of Health. Hum Reprod Update. 2018 Sep 1; 24(5):519-34.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sloan DB, Fields PD, Havird JC. Mitonuclear Linkage Disequilibrium in Human Populations. Proc Biol Sci. 2015 Sep 22;282(1815): 20151704.</mixed-citation><mixed-citation xml:lang="en">Sloan DB, Fields PD, Havird JC. Mitonuclear Linkage Disequilibrium in Human Populations. Proc Biol Sci. 2015 Sep 22;282(1815): 20151704.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zaidi AA, Makova KD. Investigating Mitonuclear Interactions in Human Admixed Populations. Nat Ecol Evol. 2019 Feb;3(2):213-22.</mixed-citation><mixed-citation xml:lang="en">Zaidi AA, Makova KD. Investigating Mitonuclear Interactions in Human Admixed Populations. Nat Ecol Evol. 2019 Feb;3(2):213-22.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Morrow EH, Camus MF. Mitonuclear Epistasis and Mitochondrial Disease. Mitochondrion. 2017 Jul;35:119-122. doi: 10.1016/j.mito.2017.06.001. Epub 2017 Jun 7.</mixed-citation><mixed-citation xml:lang="en">Morrow EH, Camus MF. Mitonuclear Epistasis and Mitochondrial Disease. Mitochondrion. 2017 Jul;35:119-122. doi: 10.1016/j.mito.2017.06.001. Epub 2017 Jun 7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Andrews SJ, Fulton-Howard B, Patterson C, et al. Mitonuclear interactions influence Alzheimer’s disease risk. Neurobiol Aging. 2020 Mar;87:138.e7-138.e14. doi: 10.1016/j.neurobiolaging.2019.09.007. Epub 2019 Sep 24.</mixed-citation><mixed-citation xml:lang="en">Andrews SJ, Fulton-Howard B, Patterson C, et al. Mitonuclear interactions influence Alzheimer’s disease risk. Neurobiol Aging. 2020 Mar;87:138.e7-138.e14. doi: 10.1016/j.neurobiolaging.2019.09.007. Epub 2019 Sep 24.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Schulmann A, Ryu E, Goncalves V, et al. Novel Complex Interactions Between Mitochondrial and Nuclear DNA in Schizophrenia and Bipolar Disorder. Mol Neuropsychiatry. 2019 Mar;5(1):13-27. doi: 10.1159/000495658. Epub 2019 Feb 5.</mixed-citation><mixed-citation xml:lang="en">Schulmann A, Ryu E, Goncalves V, et al. Novel Complex Interactions Between Mitochondrial and Nuclear DNA in Schizophrenia and Bipolar Disorder. Mol Neuropsychiatry. 2019 Mar;5(1):13-27. doi: 10.1159/000495658. Epub 2019 Feb 5.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kozin MS, Kulakova OG, Kiselev IS, et al. Variants of Mitochondrial Genome and Risk of Multiple Sclerosis Development in Russians. Acta Naturae. Oct-Dec 2018;10(4):79-86.</mixed-citation><mixed-citation xml:lang="en">Kozin MS, Kulakova OG, Kiselev IS, et al. Variants of Mitochondrial Genome and Risk of Multiple Sclerosis Development in Russians. Acta Naturae. Oct-Dec 2018;10(4):79-86.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kiselev I, Bashinskaya V, Baulina N, et al. Genetic Differences Between Primary Progressive and Relapsing-Remitting Multiple Sclerosis: The Impact of Immune-Related Genes Variability. Mult Scler Relat Disord. 2019 Apr;29:130-136. doi: 10.1016/j.msard.2019.01.033. Epub 2019 Jan 24.</mixed-citation><mixed-citation xml:lang="en">Kiselev I, Bashinskaya V, Baulina N, et al. Genetic Differences Between Primary Progressive and Relapsing-Remitting Multiple Sclerosis: The Impact of Immune-Related Genes Variability. Mult Scler Relat Disord. 2019 Apr;29:130-136. doi: 10.1016/j.msard.2019.01.033. Epub 2019 Jan 24.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Polman CH, Reingold SC, Banwell B, et al. Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria. Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.</mixed-citation><mixed-citation xml:lang="en">Polman CH, Reingold SC, Banwell B, et al. Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria. Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Barsova RM, Lvovs D, Titov BV, et al. Variants of the Coagulation and Inflammation Genes Are Replicably Associated With Myocardial Infarction and Epistatically Interact in Russians. PLoS One. 2015 Dec 10;10(12): e0144190. doi: 10.1371/journal.pone.0144190. eCollection 2015.</mixed-citation><mixed-citation xml:lang="en">Barsova RM, Lvovs D, Titov BV, et al. Variants of the Coagulation and Inflammation Genes Are Replicably Associated With Myocardial Infarction and Epistatically Interact in Russians. PLoS One. 2015 Dec 10;10(12): e0144190. doi: 10.1371/journal.pone.0144190. eCollection 2015.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yu X, Koczan D, Sulonen AM, et al. mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis. PLoS One. 2008 Feb 13;3(2): e1530. doi: 10.1371/journal.pone.0001530.</mixed-citation><mixed-citation xml:lang="en">Yu X, Koczan D, Sulonen AM, et al. mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis. PLoS One. 2008 Feb 13;3(2): e1530. doi: 10.1371/journal.pone.0001530.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tranah GJ, Santaniello A, Caillier SJ, et al. Mitochondrial DNA Sequence Variation in Multiple Sclerosis. Neurology. 2015 Jul 28;85(4): 325-30. doi: 10.1212/WNL.0000000000001744. Epub 2015 Jul 1.</mixed-citation><mixed-citation xml:lang="en">Tranah GJ, Santaniello A, Caillier SJ, et al. Mitochondrial DNA Sequence Variation in Multiple Sclerosis. Neurology. 2015 Jul 28;85(4): 325-30. doi: 10.1212/WNL.0000000000001744. Epub 2015 Jul 1.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
